以多孔辅料为载体的固体分散体改善难溶性药物溶出度的研究进展

姜红,张定堃,韩雪,贺亚男,许润春,杨明,韩丽,谭庆刍

中国药学杂志 ›› 2017, Vol. 52 ›› Issue (17) : 1477-1482.

PDF(1652 KB)
PDF(1652 KB)
中国药学杂志 ›› 2017, Vol. 52 ›› Issue (17) : 1477-1482. DOI: 10.11669/cpj.2017.17.001
综述

以多孔辅料为载体的固体分散体改善难溶性药物溶出度的研究进展

  • 姜红1,张定堃1*,韩雪1,贺亚男1,许润春1,杨明2,韩丽1*,谭庆刍1
作者信息 +

Research Progress of Solid Dispersion of Porous Material as Carrier to Improve the Dissolution Rate of Poorly Water-Soluble Drugs

  • JIANG Hong1, ZHANG Ding-kun1*, HAN Xue1, HE Ya-nan1, XU Run-chun1, YANG Ming2, HAN Li1*, TAN Qing-chu1
Author information +
文章历史 +

摘要

溶解性是制约生物药剂学分类系统(BCS)Ⅱ类药物成药性与临床应用的关键。将药物制备成固体分散体是一种提高溶出度的有效方法。随着多孔辅料的不断研发与涌现,其独特的结构优势,使得其作为载体制备固体分散体成为药剂学研究的热点。基于此,笔者阐释了多孔辅料的概念与特点,总结了孔径大小、孔有序性及表面基团对释药性能的影响,介绍了以多孔辅料为载体的固体分散体的制备方法,归纳了常用的多孔辅料的分类、特点及应用,以期推动多孔辅料在难溶性药物中的应用,提高药物的生物利用度。

Abstract

Drug solubility is the key factor that restricts the forming and clinical application of drugs in class II of the biopharmaceutics classification system (BCS). At present, making drugs into solid dispersion is an effective method to improve the dissolution rate. And with the research and development of mesoporous materials, using porous materials as the carrier to prepare solid dispersion becomes a hot research topic in recent years because of their unique structure advantages. Therefore,this paper elaborates the concept and characteristics of porous materials, summarizes the effects of pore size and ordered and surface groups on drug release properties, introduces the preparation method of solid dispersions with porous materials as the carrier, and finally summarizes the classification,characteristics and applications of the common porous materials in order to promote the application of porous materials in the pharmaceutical preparation of poorly water-soluble drugs and improve their bioavailability.

关键词

多孔辅料 / 固体分散体 / 结构特点 / 介孔二氧化硅 / 多孔淀粉 / 羟基磷灰石 / 多孔 / 氧化锌

Key words

porous material / solid dispersion / structure characteristics / mesoporous silica / porous starch / hydroxyapatite / porous / zinc oxide

引用本文

导出引用
姜红,张定堃,韩雪,贺亚男,许润春,杨明,韩丽,谭庆刍. 以多孔辅料为载体的固体分散体改善难溶性药物溶出度的研究进展[J]. 中国药学杂志, 2017, 52(17): 1477-1482 https://doi.org/10.11669/cpj.2017.17.001
JIANG Hong, ZHANG Ding-kun, HAN Xue, HE Ya-nan, XU Run-chun, YANG Ming, HAN Li, TAN Qing-chu. Research Progress of Solid Dispersion of Porous Material as Carrier to Improve the Dissolution Rate of Poorly Water-Soluble Drugs[J]. Chinese Pharmaceutical Journal, 2017, 52(17): 1477-1482 https://doi.org/10.11669/cpj.2017.17.001
中图分类号: R944   

参考文献

[1] LI H D, YIN D D, WANG X L. Solubilizing techniques and their applications to water-insoluble drug preparations[J]. Tianjin Pharm(天津药学), 2010, 22(1):60-67.
[2] ZHONG H, ZHU Y, YU J N, et al. Research progress on the solubilization of insoluble natural drugs[J]. China J Chin Mater Med(中国中药杂志), 2014,39 (17):3226-3231.
[3] ZHANG D K, LIN J Z, QIN C F, et al. Influence of micronization of andrographolide on micromeritic properties and dissolution[J]. Chin J Pharm(中国医药工业杂志), 2014, 45(4):325-329.
[4] VAN D T, VAN D M G. The role of the carrier in the formulation of pharmaceutical solid dispersions. Part I: crystalline and semi-crystalline carriers[J]. Expert Opin Drug Deliv, 2016, 13(11):1583-1594.
[5] ZHANG J, L Y, DU G H. Progress in the research of amorphous pharmaceuticals[J]. Acta Pharm Sin(药学学报), 2009, 44 (5):443-448.
[6] YAO J, SHI N Q, WANG X L. The development of co-amorphous drug systems[J]. Acta Pharm Sin (药学学报), 2013, 48(5):648-654.
[7] VAN D T, VAN D M G. The role of the carrier in the formulation of pharmaceutical solid dispersions. PartⅡ:amorphous carriers[J]. Expert Opin Drug Deliv, 2016, 17(1): 1-14.
[8] NUMPILAI T, MUENMEE S, WITOON T. Impact of pore characteristics of silica materials on loading capacity and release behavior of ibuprofen[J]. Mater Sci Eng C Mater Biol Appl, 2016, 59: 43-52.
[9] SANTOS H A, PELTONEN L, LIMENELL T, et al. Mesoporous materials and nanocrystals for enhancing the dissolution behavior of poorly water-soluble drugs[J]. Curr Pharm Biotechnol, 2013, 14(10):926-938.
[10] TIAN B S, LI Q F, LIU S H, et al. Adsorption and slow release properties of amino functionalized mesoporous silica on Bloven[J]. Chem Res Appl(化学研究与应用), 2014, 26(4):561-565.
[11] TANG Q Q, YUAN L, YANG D, et al. Preparation and characterization of mesoporous silica microspheres modified with two sulfur bonds[J]. Acta Chim Sin (化学学报), 2010, 68(18):1925-1929.
[12] XIE Z F. Research on mesoporous silica nanoparticles functionalized with PEG via a disulfide bond as drug delivery system [D]. Shijiazhuang:Hubei University Technology, 2015.
[13] ZHANG X H, XIA H L. Physical Chemistry(物理化学)[M]. Beijing: People Public Health Publishing House, 2012: 216.
[14] ZHANG D, LIN J, ZHANG F, et al. Preparation and evaluation of andrographolide solid dispersion vectored by silicon dioxide[J]. Pharmacogn Mag, 2016, 12(suppl 2):245-252.
[15] WANG Y Z, SUN L Z, SONG A H, et al. Synthesis of mesoprous silica nanoparticles and their effects on drug loading and dissolution[J]. J Shenyang Pharm Univ(沈阳药科大学学报), 2012, 29(4):258-263.
[16] YAN H M, JIA X B, ZHANG Z H, et al. Study on porous starch as solid dispersion carrier of total epimedium[J]. China J Chin Mater Med(中国中药杂志), 2015, 40(9):1723-1726.
[17] GAO B, SUN C S, ZHI Z Z, et al. Preparation of two poor water soluble drugs-nanoporous ZnO solid dispersions and the mechanism of drug dissolution improvement[J]. Acta Pharm Sin(药学学报), 2011, 46(11):1399-1407.
[18] WANG T Y, ZHAO Q F, HAN X, et al. Application of two kinds of mesoporous silica for preparation of nimodiine solid disersion[J]. Chin Pharm J (中国药学杂志), 2014, 49(13): 1139-1145.
[19] JIANG Y R, ZHANG Z H, DING D M, et al. Comparative study on the preparation of the solid dispersion of the red sage ketone porous silica[J]. China J Chin Mater Med(中国中药杂志), 2013, 38(19):3271-3276.
[20] ZHOU H Y. Synthesis, Characterization and Application of Functionalized Mesoporous Silica [D]. Nanning:Guangxi University of Traditional Chinese Medicine, 2014.
[21] WANG X, TENG Z G, HUANG X Y, et al. Mesoporous silica nanoparticles for cancer theranostic drug delivery [J]. Acta Pharm Sin(药学学报), 2013,48(1):8-13.
[22] SANTOS H A, PELTONEN L, LIMNELL T, et al. Mesoporous materials and nanocrystals for enhancing the dissolution behavior of poorly water-soluble drugs[J]. Curr Pharm Biotechnol, 2013, 14(10):926-938.
[23] WANG Y, SUN L, JIANG T, et al. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol[J]. Drug Dev Ind Pharm, 2014, 40(6):819-828.
[24] SHAN X J, YAN Z K, YU C F, et al. Preparation of celecoxib/mesoporous silicon SBA-15 solid dispersion and its characteristics[J]. Cent South Pharm(中南药学), 2015, 13(9):935-938.
[25] CHEN M J, ZHANG Y Z, HAN X, et al. Preparation and characterization of solid dispersion tablets based on mesoporous silica[J]. J Shenyang Pharm Univ(沈阳药科大学学报), 2013, 30(1):8-12.
[26] MALEKI A, HAMIDI M. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers[J]. Expert Opin Drug Deliv, 2016, 13(2):171-181.
[27] HE L L, YUAN Z X, ZHENG Y, et al. Preparation and characterization of curcumin solid dispersion using mesoporous silica nanoparticle[J]. Chin Tradit Herb Drugs(中草药), 2016, 47(13):2283-2287.
[28] NIEMELA E, DESAI D, NKIZINKIKO Y, et al. Sugar-decorated mesoporous silica nanoparticles as delivery vehicles for the poorly soluble drug celastrol enables targeted induction of apoptosis in cancer cells[J]. Eur J Pharm Biopharm, 2015, 96: 11-21.
[29] WU P L, ZHANG L M, YANG X, et al. Study on the adsorption properties of corn porous starch on tea polyphenols[J]. Mod Food Sci Technol(现代食品科技), 2010, 26(9):938-941.
[30] JIANG Y R, ZHANG Z H, DING D M, et al. Study on preparation and powder of coix seed oil corn porous starch[J]. China J Chin Mater Med(中国中药杂志), 2013, 38(14):2287-2291.
[31] ALI M T, FULE R, SAV A, et al. Porous starch: a novel carrier for solubility enhancement of carbamazepine[J]. AAPS Pharm Sci Tech, 2013, 14(3):919-926.
[32] WU C, WANG Z, ZHI Z, et al. Development of biodegradable porous starch foam for improving oral delivery of poorly water soluble drugs[J]. Int J Pharm, 2011, 403(1-2):162-169.
[33] ZHANG Z, HUANG J, JIANG S, et al. Porous starch based self-assembled nano-delivery system improves the oral absorption of lipophilic drug[J]. Int J Pharm, 2013, 444(1-2):162-168.
[34] ZHAO Q F, ZHEN L, WANG S L, et al. Preparation methods of nano-porous hydroxyapatite and its application in drug delivery[J]. J Shenyang Pharm Univ(沈阳药科大学学报), 2010, 27(12):1009-1013.
[35] SHI J J, SONG Z Y, QI Z P, et al. Study on the preparation of gentamicin porous hydroxyapatite microspheres by the method of emulsion[J]. Chin Hosp Pharm J(中国医院药学杂志), 2013, 33(14):1149-1152.
[36] HU S Y, ZHANG Z H, JIA X B. Study on andrographolide solid dispersion with hydroxyapatite as carrier[J]. China J Chin Mater Med(中国中药杂志), 2013, 38(3):341-345.
[37] HUANG F F. Preparation of porous hydroxyapatite and the properties of drug delivery in vitro [D]. Xi′an:Shanxi University of Science and Technology, 2012.
[38] ZHANG X Y, ZHU L, ZHU L L, et al. Study on preparation of mesoporous alumina and its adsorption properties for normal[J]. Mater Rev(材料导报), 2013,27(10):99-103.
[39] KAPOOR S, HEGDE R, BHATTACHARYYA A J. Influence of surface chemistry of mesoporous alumina with wide pore distribution on controlled drug release[J]. J Controlled Release, 2009, 140(1):34-39.
[40] FANG Y Y, ZHEN G L. Research progress of montmorillonite as drug carrier[J]. Chin J Clin Pharmacol Ther(中药临床药理学与治疗学), 2011, 16(8):956-960.
[41] JIN X, WANG Q W, HU T N, et al. Modified montmorillonite as multifunction gene and drug delivery system [J].J Zhejiang Univ(Med Sci) (浙江大学学报 医学版), 2012, 41(6):631-638.
[42] LIU D, TANG C C, XUE Y M, et al. Novel porous boron nitride material[J]. Prog Chem(化学进展), 2013, 25(7):1113-1121.
[43] XIAO X. Investigation on the synthesis of porous boron nitride and adsorption characteristics for congo red and rhodmine b [D]. Shijiazhuang:Hebei University Technology, 2015.

基金

国家自然科学基金资助项目(81274098);国家基础科学人才培养基金资助项目(J13100340-19)
PDF(1652 KB)

Accesses

Citation

Detail

段落导航
相关文章

/